Faecal Microbiota Transplant(FMT) Therapy - Global and China Top Players Market Share and Ranking 2023
This report studies and analyses global Faecal Microbiota Transplant(FMT) Therapy status and future trends, to help determine the Faecal Microbiota Transplant(FMT) Therapy market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Faecal Microbiota Transplant(FMT) Therapy, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Faecal Microbiota Transplant(FMT) Therapy market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Faecal Microbiota Transplant(FMT) Therapy by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Faecal Microbiota Transplant(FMT) Therapy by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Faecal Microbiota Transplant(FMT) Therapy key consuming regions, consumption value and demand structure
(5) Faecal Microbiota Transplant(FMT) Therapy industry chains, upstream, midstream and downstream
According to YH Research, the global market for Faecal Microbiota Transplant(FMT) Therapy should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Faecal Microbiota Transplant(FMT) Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Faecal Microbiota Transplant(FMT) Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Clostridioides Difficile Infection(CDI) grew percent to account for percent of the total market sales, and Digestive System Disease grew percent.
Market segment by players, this report covers
Enterome Bioscience
Rebiotix
Ritter Pharmaceuticals
Finch Therapeutics
Crestovo
Maat Pharma
Seres Therapeutics
Second Genome
OpenBiome
MicroBiome Therapeutics
Market segment by Type, covers
Oral
Enema
Market segment by Application, can be divided into
Clostridioides Difficile Infection(CDI)
Digestive System Disease
Nervous System Disease
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Faecal Microbiota Transplant(FMT) Therapy product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Faecal Microbiota Transplant(FMT) Therapy market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Faecal Microbiota Transplant(FMT) Therapy market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Faecal Microbiota Transplant(FMT) Therapy industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Faecal Microbiota Transplant(FMT) Therapy Definition
1.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast
1.3 China Faecal Microbiota Transplant(FMT) Therapy Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Faecal Microbiota Transplant(FMT) Therapy Market Size: China VS Global Growth Rate, 2018-2029
1.6 Faecal Microbiota Transplant(FMT) Therapy Market Dynamics
1.6.1 Faecal Microbiota Transplant(FMT) Therapy Market Drivers
1.6.2 Faecal Microbiota Transplant(FMT) Therapy Market Restraints
1.6.3 Faecal Microbiota Transplant(FMT) Therapy Industry Trends
1.6.4 Faecal Microbiota Transplant(FMT) Therapy Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Faecal Microbiota Transplant(FMT) Therapy, Global Market Share by Company, 2018-2023
2.2 Global Faecal Microbiota Transplant(FMT) Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Faecal Microbiota Transplant(FMT) Therapy Concentration Ratio
2.4 Global Faecal Microbiota Transplant(FMT) Therapy Mergers & Acquisitions, Expansion Plans
2.5 Global Faecal Microbiota Transplant(FMT) Therapy Major Companies Product Type
2.6 Head Office and Faecal Microbiota Transplant(FMT) Therapy Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Faecal Microbiota Transplant(FMT) Therapy, China Market Share by Company, 2018-2023
3.2 China Faecal Microbiota Transplant(FMT) Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Faecal Microbiota Transplant(FMT) Therapy Industry Chain
4.2 Faecal Microbiota Transplant(FMT) Therapy Upstream Analysis
4.2.1 Faecal Microbiota Transplant(FMT) Therapy Core Raw Materials
4.2.2 Main Manufacturers of Faecal Microbiota Transplant(FMT) Therapy Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Faecal Microbiota Transplant(FMT) Therapy Production Mode
4.6 Faecal Microbiota Transplant(FMT) Therapy Procurement Model
4.7 Faecal Microbiota Transplant(FMT) Therapy Industry Sales Model and Sales Channels
4.7.1 Faecal Microbiota Transplant(FMT) Therapy Sales Model
4.7.2 Faecal Microbiota Transplant(FMT) Therapy Typical Distributors
5 Sights by Type
5.1 Faecal Microbiota Transplant(FMT) Therapy Classification
5.1.1 Oral
5.1.2 Enema
5.2 By Type, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029
6 Sights by Application
6.1 Faecal Microbiota Transplant(FMT) Therapy Segment by Application
6.1.1 Clostridioides Difficile Infection(CDI)
6.1.2 Digestive System Disease
6.1.3 Nervous System Disease
6.1.4 Others
6.2 By Application, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Faecal Microbiota Transplant(FMT) Therapy & Forecasts, 2018-2029
7.3.2 By Country, North America Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share
7.4 Europe
7.4.1 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share
7.6 South America
7.6.1 South America Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Faecal Microbiota Transplant(FMT) Therapy Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.3.2 By Type, U.S. Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.4.2 By Type, Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.5.2 By Type, China Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.6.2 By Type, Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.7.2 By Type, South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.9.2 By Type, India Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Enterome Bioscience
9.1.1 Enterome Bioscience Company Information, Head Office, Market Area and Industry Position
9.1.2 Enterome Bioscience Company Profile and Main Business
9.1.3 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.1.4 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.1.5 Enterome Bioscience Recent Developments
9.2 Rebiotix
9.2.1 Rebiotix Company Information, Head Office, Market Area and Industry Position
9.2.2 Rebiotix Company Profile and Main Business
9.2.3 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.2.4 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.2.5 Rebiotix Recent Developments
9.3 Ritter Pharmaceuticals
9.3.1 Ritter Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.3.2 Ritter Pharmaceuticals Company Profile and Main Business
9.3.3 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.3.4 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.3.5 Ritter Pharmaceuticals Recent Developments
9.4 Finch Therapeutics
9.4.1 Finch Therapeutics Company Information, Head Office, Market Area and Industry Position
9.4.2 Finch Therapeutics Company Profile and Main Business
9.4.3 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.4.4 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.4.5 Finch Therapeutics Recent Developments
9.5 Crestovo
9.5.1 Crestovo Company Information, Head Office, Market Area and Industry Position
9.5.2 Crestovo Company Profile and Main Business
9.5.3 Crestovo Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.5.4 Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.5.5 Crestovo Recent Developments
9.6 Maat Pharma
9.6.1 Maat Pharma Company Information, Head Office, Market Area and Industry Position
9.6.2 Maat Pharma Company Profile and Main Business
9.6.3 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.6.4 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.6.5 Maat Pharma Recent Developments
9.7 Seres Therapeutics
9.7.1 Seres Therapeutics Company Information, Head Office, Market Area and Industry Position
9.7.2 Seres Therapeutics Company Profile and Main Business
9.7.3 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.7.4 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.7.5 Seres Therapeutics Recent Developments
9.8 Second Genome
9.8.1 Second Genome Company Information, Head Office, Market Area and Industry Position
9.8.2 Second Genome Company Profile and Main Business
9.8.3 Second Genome Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.8.4 Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.8.5 Second Genome Recent Developments
9.9 OpenBiome
9.9.1 OpenBiome Company Information, Head Office, Market Area and Industry Position
9.9.2 OpenBiome Company Profile and Main Business
9.9.3 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.9.4 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.9.5 OpenBiome Recent Developments
9.10 MicroBiome Therapeutics
9.10.1 MicroBiome Therapeutics Company Information, Head Office, Market Area and Industry Position
9.10.2 MicroBiome Therapeutics Company Profile and Main Business
9.10.3 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications and Application
9.10.4 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, 2018-2023
9.10.5 MicroBiome Therapeutics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Faecal Microbiota Transplant(FMT) Therapy Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Faecal Microbiota Transplant(FMT) Therapy Market Restraints
Table 3. Faecal Microbiota Transplant(FMT) Therapy Market Trends
Table 4. Faecal Microbiota Transplant(FMT) Therapy Industry Policy
Table 5. Global Faecal Microbiota Transplant(FMT) Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Faecal Microbiota Transplant(FMT) Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Faecal Microbiota Transplant(FMT) Therapy Mergers & Acquisitions, Expansion Plans
Table 9. Global Faecal Microbiota Transplant(FMT) Therapy Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Faecal Microbiota Transplant(FMT) Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Faecal Microbiota Transplant(FMT) Therapy Upstream (Raw Materials)
Table 14. Global Faecal Microbiota Transplant(FMT) Therapy Typical Customers
Table 15. Faecal Microbiota Transplant(FMT) Therapy Typical Distributors
Table 16. By Type, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2018-2029
Table 23. Enterome Bioscience Company Information, Head Office, Market Area and Industry Position
Table 24. Enterome Bioscience Company Profile and Main Business
Table 25. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Models, Specifications, and Application
Table 26. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Enterome Bioscience Recent Developments
Table 28. Rebiotix Company Information, Head Office, Market Area and Industry Position
Table 29. Rebiotix Company Profile and Main Business
Table 30. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Models, Specifications, and Application
Table 31. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Rebiotix Recent Developments
Table 33. Ritter Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 34. Ritter Pharmaceuticals Company Profile and Main Business
Table 35. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Models, Specifications, and Application
Table 36. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Ritter Pharmaceuticals Recent Developments
Table 38. Finch Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 39. Finch Therapeutics Company Profile and Main Business
Table 40. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications, and Application
Table 41. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Finch Therapeutics Recent Developments
Table 43. Crestovo Company Information, Head Office, Market Area and Industry Position
Table 44. Crestovo Company Profile and Main Business
Table 45. Crestovo Faecal Microbiota Transplant(FMT) Therapy Models, Specifications, and Application
Table 46. Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Crestovo Recent Developments
Table 48. Maat Pharma Company Information, Head Office, Market Area and Industry Position
Table 49. Maat Pharma Company Profile and Main Business
Table 50. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Models, Specifications, and Application
Table 51. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Maat Pharma Recent Developments
Table 53. Seres Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 54. Seres Therapeutics Company Profile and Main Business
Table 55. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications, and Application
Table 56. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Seres Therapeutics Recent Developments
Table 58. Second Genome Company Information, Head Office, Market Area and Industry Position
Table 59. Second Genome Company Profile and Main Business
Table 60. Second Genome Faecal Microbiota Transplant(FMT) Therapy Models, Specifications, and Application
Table 61. Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Second Genome Recent Developments
Table 63. OpenBiome Company Information, Head Office, Market Area and Industry Position
Table 64. OpenBiome Company Profile and Main Business
Table 65. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Models, Specifications, and Application
Table 66. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. OpenBiome Recent Developments
Table 68. MicroBiome Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 69. MicroBiome Therapeutics Company Profile and Main Business
Table 70. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Models, Specifications, and Application
Table 71. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. MicroBiome Therapeutics Recent Developments
List of Figures
Figure 1. Faecal Microbiota Transplant(FMT) Therapy Picture
Figure 2. Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Faecal Microbiota Transplant(FMT) Therapy Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Faecal Microbiota Transplant(FMT) Therapy Market Share of Global, 2018-2029
Figure 5. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Faecal Microbiota Transplant(FMT) Therapy Key Participants, Market Share, 2022
Figure 7. Faecal Microbiota Transplant(FMT) Therapy Industry Chain
Figure 8. Faecal Microbiota Transplant(FMT) Therapy Procurement Model
Figure 9. Faecal Microbiota Transplant(FMT) Therapy Sales Model
Figure 10. Faecal Microbiota Transplant(FMT) Therapy Sales Channels, Direct Sales, and Distribution
Figure 11. Oral
Figure 12. Enema
Figure 13. By Type, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Figure 14. By Type, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2018-2029
Figure 15. Clostridioides Difficile Infection(CDI)
Figure 16. Digestive System Disease
Figure 17. Nervous System Disease
Figure 18. Others
Figure 19. By Application, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Figure 20. By Application, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2018-2029
Figure 21. By Region, Global Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2018-2029
Figure 22. North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022
Figure 24. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022
Figure 26. Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022
Figure 28. South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022
Figure 30. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Figure 32. By Type, U.S. Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 34. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Figure 35. By Type, Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 36. By Application, Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 37. China Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Figure 38. By Type, China Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 39. By Application, China Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 40. Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Figure 41. By Type, Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 42. By Application, Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 43. South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Figure 44. By Type, South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 45. By Application, South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 46. Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Figure 47. By Type, Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 48. By Application, Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 49. India Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Figure 50. By Type, India Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 51. By Application, India Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 52. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value, 2018-2029, US$ Million
Figure 53. By Type, Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 54. By Application, Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share, 2022 VS 2029
Figure 55. Research Methodology
Figure 56. Breakdown of Primary Interviews
Figure 57. Bottom-up and Top-down Approaches
Figure 58. Top-down Approaches
Reason to Buy
- Current and future of Uncategorized Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Uncategorized Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets